COMMON STOCK PURCHASE WARRANT PRESSURE BIOSCIENCES, INC.Pressure Biosciences Inc • June 15th, 2018 • Laboratory analytical instruments • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [HOLDER] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [Month Day, 2018] (the “Initial Exercise Date”) and on or prior to the close of business on the five year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Pressure BioSciences, Inc., a Massachusetts corporation (the “Company”), up to [xxxxxxx] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Re: Agreement to Amend Conversion Price and Convert – LOC Obligation;Via Electronic Mail • June 15th, 2018 • Pressure Biosciences Inc • Laboratory analytical instruments • Massachusetts
Reference is made to that certain October 26, 2016 Promissory Note, as amended pursuant to Amendment 1 on May 2, 2017, Amendment 2 on August 18, 2017, and Amendment 3 on January 30, 2018, in the Principal Amount of $4,000,000 (the “Promissory Note”) issued by the Company to you and Common Stock Purchase Warrants issued in connection therewith (the “Line of Credit Warrants” and, together with the Promissory Note, the “Line of Credit Documents”).
Re: Agreement to Convert Debentures;Electronic Mail • June 15th, 2018 • Pressure Biosciences Inc • Laboratory analytical instruments • Massachusetts
Reference is made to that certain Subscription Agreement (the “Subscription Agreement”), entered into between July 22, 2015 and March 31, 2016 by and among Pressure BioSciences, Inc. (the “Company”) and the holders of the Company’s Senior Secured Convertible Debentures (the “Debenture Holders”); and those certain Senior Secured Convertible Debentures (each a “Debenture” and, together, the “Debentures”) and Common Stock Purchase Warrants issued in connection therewith (the “Debenture Warrants” and, together with the Subscription Agreement and Debentures, the “Debenture Documents”). You are being sent this letter as you are currently the holder of: (i) a Debenture pursuant to which you are owed principal along with accrued interest (the “Debenture Obligation”); and (ii) Debenture Warrants.
Re: Agreement to Convert – May 2017 Promissory Note ObligationVia Electronic Mail • June 15th, 2018 • Pressure Biosciences Inc • Laboratory analytical instruments
Reference is made to that certain May 19, 2017 Promissory Note, in the Principal Amount of $630,000 (the “Promissory Note”), issued by the Company to you (the “May 2017 Promissory Note Documents”).
